Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
69.17
+2.17 (3.24%)
At close: Nov 12, 2025
51.60%
Market Cap30.44B
Revenue (ttm)10.59B
Net Income (ttm)227.00M
Shares Outn/a
EPS (ttm)0.52
PE Ratio134.09
Forward PE19.45
Dividend0.73 (1.06%)
Ex-Dividend DateApr 17, 2025
Volume181
Average Volume320
Open69.17
Previous Close67.00
Day's Range69.17 - 69.17
52-Week Range36.68 - 69.17
Beta0.27
RSI75.31
Earnings DateFeb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.